Daniel P. Radin

PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: Involvement of ROS and mitophagy

Katherine Dai, Daniel P. Radin, Donna Leonardi · Pharmacological Reports · 2019 · 37 citations

Pink1 Depletion, Glycolytic Inhibitor, Oncology +12

Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells

Daniel P. Radin, Arnold Lippa, Parth Patel et al. · Biomedicine & Pharmacotherapy · 2015 · 36 citations

Cisplatin Resistance, Breast Oncology, Lifeguard Inhibition +11

A distinct microglial subset at the <scp>tumor–stroma</scp> interface of glioma

Michael D. Caponegro, Ki Oh, Miguel M. Madeira et al. · Glia · 2021 · 30 citations · Full text

Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain

Daniel P. Radin, Steve A. Johnson, Richard Purcell et al. · Biomedicine & Pharmacotherapy · 2018 · 29 citations

Neuromodulation, Neurophysiology, Medicine +12

Acute ampakine treatment ameliorates age-related deficits in long-term potentiation

Daniel P. Radin, Sheng Zhong, Richard Purcell et al. · Biomedicine & Pharmacotherapy · 2016 · 24 citations

Geriatric Endocrinology, Aging, Neurophysiology +6